<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1688-0390</journal-id>
<journal-title><![CDATA[Revista Médica del Uruguay]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Méd. Urug.]]></abbrev-journal-title>
<issn>1688-0390</issn>
<publisher>
<publisher-name><![CDATA[Sindicato Médico del Uruguay]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1688-03902026000101201</article-id>
<article-id pub-id-type="doi">10.29193/rmu.42.1.1</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Prevalencia y caracterización de pacientes con historia de consumo de sustancias de abuso en una unidad de medicina intensiva en Uruguay en 2013 y 2023]]></article-title>
<article-title xml:lang="en"><![CDATA[Prevalence and characterisation of patients with a history of substance abuse in an intensive care unit in uruguay in 2013 and 2023]]></article-title>
<article-title xml:lang="pt"><![CDATA[Prevalência e Caracterização de Pacientes com Histórico de Uso de Substâncias de Abuso em uma Unidade de Terapia Intensiva no Uruguai em 2013 e 2023]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Clouzet]]></surname>
<given-names><![CDATA[Vanina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Varela]]></surname>
<given-names><![CDATA[Florencia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Valiente]]></surname>
<given-names><![CDATA[Agustín]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Nin]]></surname>
<given-names><![CDATA[Catalina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Viñales]]></surname>
<given-names><![CDATA[Martina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Tenzi]]></surname>
<given-names><![CDATA[Jordan]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Giordano]]></surname>
<given-names><![CDATA[Álvaro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Español Juan José Crottogini, Administración de los Servicios de Salud del Estado  ]]></institution>
<addr-line><![CDATA[Montevideo ]]></addr-line>
<country>Uruguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2026</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2026</year>
</pub-date>
<volume>42</volume>
<numero>1</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S1688-03902026000101201&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S1688-03902026000101201&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S1688-03902026000101201&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción: El consumo de sustancias de abuso es una problemática central en salud pública a nivel nacional e internacional. El perfil de los consumidores ha cambiado en los últimos años, específicamente tras la pandemia de COVID-19. Los desórdenes asociados al consumo de drogas constituyen un factor de riesgo mayor y potencialmente modificable para el desarrollo y severidad de patologías críticas, las cuales se asocian con peores resultados clínicos.  Objetivo: Determinar la prevalencia de consumo de sustancias de abuso en pacientes ingresados en una unidad de cuidados intensivos en Uruguay en dos períodos con 10 años de diferencia (2013 y 2023), así como caracterizar y comparar ambas poblaciones.  Metodología: Estudio observacional, descriptivo-analítico y retrospectivo, realizado en pacientes ingresados en una unidad de medicina intensiva en Uruguay en 2013 y 2023. Se incluyeron todos los pacientes mayores de 18 años ingresados entre mayo y octubre de esos años. Se consideraron dos grupos de pacientes con antecedentes de consumo de sustancias: uno que incluye los ingresados en 2013 y otro que incluye los ingresados en 2023.  Resultados: La prevalencia de pacientes con historia de consumo fue mayor en 2023 que en 2013 (73,2% [180/246] vs. 56,9% [198/348]); (p&lt;0,000). Los pacientes con historia de consumo de 2023 presentaron mayor prevalencia de consumo de pasta base de cocaína (p=0,031), benzodiacepinas (p&lt;0,000), policonsumo (p=0,001), así como de patologías psiquiátricas (p=0,001), neurológicas (p=0,023) y tuberculosis (p=0,021) en comparación con los de 2013.  Conclusiones: Se constató un aumento de la prevalencia de consumo de sustancias de abuso en una unidad de cuidados intensivos en Uruguay, junto con un cambio en el perfil de los consumidores en el transcurso de 10 años. Estos resultados alertan sobre un fenómeno social en evolución y nos orientan en el diseño de futuras políticas de salud.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction: The consumption of substances of abuse is a central public health issue both nationally and internationally. The profile of consumers has changed in recent years, particularly following the COVID-19 pandemic. Disorders associated with drug use represent a major and potentially modifiable risk factor for the development and severity of critical illnesses, which are associated with poorer clinical outcomes.  Objective: To determine the prevalence of substance abuse among patients admitted to an intensive care unit in Uruguay during two periods 10 years apart (2013 and 2023), and to characterise and compare these populations.  Methodology: A retrospective, observational, descriptive-analytical study was conducted on patients admitted to an intensive care unit in Uruguay in 2013 and 2023. All patients over 18 years of age admitted between May and October of those years were included. Two groups of patients with a history of substance use were considered: one including those admitted in 2013 and another including those admitted in 2023.  Results: The prevalence of patients with a history of substance use was higher in 2023 than in 2013 (73.2% [180/246] vs. 56.9% [198/348]); (p&lt;0.001). Patients with a history of substance use in 2023 showed a higher prevalence of cocaine base paste use (p=0.031), benzodiazepine use (p&lt;0.001), and polyconsumption (p=0.001), as well as psychiatric (p=0.001), neurological (p=0.023), and tuberculosis (p=0.021) comorbidities compared with those from 2013.  Conclusions: An increase in the prevalence of substance abuse was observed in an intensive care unit in Uruguay, along with a change in the profile of users over 10 years. These results highlight an ongoing social phenomenon and provide guidance for the development of future health policies.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo  Introdução: O consumo de substâncias de abuso é um problema central de saúde pública, tanto em nível nacional quanto internacional. O perfil dos consumidores mudou nos últimos anos, especialmente após a pandemia de COVID-19. Os transtornos associados ao uso de drogas representam um importante e potencialmente modificável fator de risco para o desenvolvimento e a gravidade de doenças críticas, as quais estão associadas a piores desfechos clínicos.  Objetivo: Determinar a prevalência do consumo de substâncias de abuso em pacientes internados em uma unidade de terapia intensiva no Uruguai em dois períodos com 10 anos de diferença (2013 e 2023), bem como caracterizar e comparar essas populações.  Metodologia: Estudo observacional, descritivo-analítico e retrospectivo, realizado com pacientes internados em uma unidade de terapia intensiva no Uruguai em 2013 e 2023. Foram incluídos todos os pacientes com mais de 18 anos internados entre maio e outubro desses anos. Consideraram-se dois grupos de pacientes com histórico de consumo de substâncias: um referente às internações de 2013 e outro às de 2023.  Resultados: A prevalência de pacientes com histórico de consumo foi maior em 2023 do que em 2013 (73,2% [180/246] vs. 56,9% [198/348]); (p&lt;0,001). Os pacientes com histórico de consumo em 2023 apresentaram maior prevalência de uso de pasta base de cocaína (p=0,031), benzodiazepínicos (p&lt;0,001), policonsumo (p=0,001), além de patologias psiquiátricas (p=0,001), neurológicas (p=0,023) e tuberculose (p=0,021) em comparação com os de 2013.  Conclusões: Verificou-se um aumento na prevalência do consumo de substâncias de abuso em uma unidade de terapia intensiva no Uruguai, juntamente com uma mudança no perfil dos consumidores ao longo de 10 anos. Esses resultados alertam para um fenômeno social em evolução e orientam o desenvolvimento de futuras políticas de saúde.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Sustancias de abuso]]></kwd>
<kwd lng="es"><![CDATA[Drogas]]></kwd>
<kwd lng="es"><![CDATA[Unidad de cuidados intensivos]]></kwd>
<kwd lng="en"><![CDATA[Substance abuse]]></kwd>
<kwd lng="en"><![CDATA[Drugs]]></kwd>
<kwd lng="en"><![CDATA[Intensive care unit]]></kwd>
<kwd lng="pt"><![CDATA[Substâncias de abuso]]></kwd>
<kwd lng="pt"><![CDATA[Drogas]]></kwd>
<kwd lng="pt"><![CDATA[Unidade de terapia intensiva]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1.</label><nlm-citation citation-type="book">
<collab>Junta Nacional de Drogas</collab>
<source><![CDATA[Guía Infodrogas 12.a ed. Más información, menos riesgos]]></source>
<year>2012</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[Junta Nacional de Drogas]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2.</label><nlm-citation citation-type="book">
<collab>Organización Panamericana de la Salud (OPS)</collab>
<source><![CDATA[Uso de sustancias. [Internet]]]></source>
<year></year>
<publisher-loc><![CDATA[Washington, D.C. ]]></publisher-loc>
<publisher-name><![CDATA[OPS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3.</label><nlm-citation citation-type="book">
<collab>Ministerio de Salud Pública de Uruguay</collab>
<source><![CDATA[Consumo de sustancias psicoactivas en Uruguay]]></source>
<year>2022</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio de Salud Pública]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4.</label><nlm-citation citation-type="book">
<collab>Organización Mundial de la Salud (OMS)</collab>
<source><![CDATA[Drogas: temas de salud. [Internet]]]></source>
<year></year>
<publisher-loc><![CDATA[Ginebra ]]></publisher-loc>
<publisher-name><![CDATA[OMS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5.</label><nlm-citation citation-type="book">
<collab>United Nations Office on Drugs and Crime (UNODC)</collab>
<source><![CDATA[Terminology and Information on Drugs]]></source>
<year>2016</year>
<edition>3rd ed.</edition>
<publisher-loc><![CDATA[Vienna ]]></publisher-loc>
<publisher-name><![CDATA[United Nations]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6.</label><nlm-citation citation-type="book">
<collab>United Nations Office on Drugs and Crime (UNODC)</collab>
<source><![CDATA[World Drug Report 2024]]></source>
<year>2024</year>
<publisher-loc><![CDATA[Vienna ]]></publisher-loc>
<publisher-name><![CDATA[United Nations]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7.</label><nlm-citation citation-type="book">
<collab>Junta Nacional de Drogas; Observatorio Uruguayo de Drogas</collab>
<source><![CDATA[VIII Encuesta Nacional sobre Consumo de Drogas en la Población General]]></source>
<year>2024</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[Junta Nacional de Drogas]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8.</label><nlm-citation citation-type="book">
<collab>Junta Nacional de Drogas; Observatorio Uruguayo de Drogas</collab>
<source><![CDATA[VI Encuesta Nacional en Hogares sobre Consumo de Drogas en Uruguay]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[Junta Nacional de Drogas]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9.</label><nlm-citation citation-type="book">
<collab>Junta Nacional de Drogas; Observatorio Uruguayo de Drogas</collab>
<source><![CDATA[VII Encuesta Nacional sobre Consumo de Drogas en la Población General]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[Junta Nacional de Drogas]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Steel]]></surname>
<given-names><![CDATA[TL]]></given-names>
</name>
<name>
<surname><![CDATA[Bhatraju]]></surname>
<given-names><![CDATA[EP]]></given-names>
</name>
<name>
<surname><![CDATA[Hills-Dunlap]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Critical care for patients with substance use disorders]]></article-title>
<source><![CDATA[Curr Opin Crit Care]]></source>
<year>2023</year>
<volume>29</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>484-92</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bolds]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Substance use disorder in critical care]]></article-title>
<source><![CDATA[Crit Care Nurs Clin North Am]]></source>
<year>2023</year>
<volume>35</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>469-79</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tollisen]]></surname>
<given-names><![CDATA[KH]]></given-names>
</name>
<name>
<surname><![CDATA[Bjerva]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Hadley]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[Dahl]]></surname>
<given-names><![CDATA[GT]]></given-names>
</name>
<name>
<surname><![CDATA[Högvall]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Sandvik]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Substance abuse-related admissions in a mixed Norwegian intensive care population]]></article-title>
<source><![CDATA[Acta Anaesthesiol Scand]]></source>
<year>2020</year>
<volume>64</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>329-37</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fuellis]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Verga]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Pascale]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Grille]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Barbato]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia de consumo de cocaína y cannabis en pacientes traumatizados ingresados a medicina intensiva]]></article-title>
<source><![CDATA[Rev Med Urug]]></source>
<year>2024</year>
<volume>40</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B14">
<label>14.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Céspedes Bustamante]]></surname>
<given-names><![CDATA[EC]]></given-names>
</name>
<name>
<surname><![CDATA[Molina Aneiros]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Campdesuñer Beltrán]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Chacón Reyes]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Consumo de sustancias y sus implicaciones en la salud mental]]></article-title>
<source><![CDATA[Rev Hosp Psiquiátrico Habana]]></source>
<year>2014</year>
<volume>11</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-10</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15.</label><nlm-citation citation-type="book">
<collab>Junta Nacional de Drogas; Observatorio Uruguayo de Drogas</collab>
<article-title xml:lang=""><![CDATA[Personas, calle, consumos: dos estudios sobre uso de pasta base en Uruguay]]></article-title>
<source><![CDATA[Aproximaciones cuantitativas y etnográficas]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[Junta Nacional de Drogas]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<label>16.</label><nlm-citation citation-type="book">
<collab>United Nations Office on Drugs and Crime (UNODC)</collab>
<source><![CDATA[World Drug Report 2013]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Vienna ]]></publisher-loc>
<publisher-name><![CDATA[United Nations]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<label>17.</label><nlm-citation citation-type="book">
<collab>United Nations Office on Drugs and Crime (UNODC)</collab>
<source><![CDATA[World Drug Report 2023]]></source>
<year>2023</year>
<publisher-loc><![CDATA[Vienna ]]></publisher-loc>
<publisher-name><![CDATA[United Nations]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
